GlassScriptPhysician profile
Randall K Barrett
NPI 1043294317
$2,133.81
in general payments reported to CMS, 2019-2025
15 companies · $112 in 2025
The $112 reported for 2025 was more than what a typical Anesthesiology provider received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $186 · 2020: $106 · 2021: $1,262 · 2022: $173 · 2023: $195 · 2024: $100 · 2025: $112.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $407.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $407.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $1,179.34 | 2021 | |
| Abbott Laboratories | $310.13 | 2019-2022 | |
| Collegium Pharmaceutical, INC. | $202.61 | 2019-2025 | Belbuca, Xtampza |
| Spr Therapeutics, INC | $191.98 | 2023-2025 | Sprint Pns System |
| Boston Scientific Corporation | $59.53 | 2019-2025 | Wavewriter Alpha Prime 16, General - Pain Management |
| Biodelivery Sciences International, INC. | $25.69 | 2020 | |
| Si-Bone, INC. | $22.16 | 2024 | |
| Nevro Corp. | $20.79 | 2019 | |
| Csl Behring | $20.70 | 2023 | Kcentra |
| Pacira Therapeutics, INC. | $19.00 | 2020 | |
| Assertio Therapeutics, INC. | $18.04 | 2019 | |
| Medtronic USA, INC. | $16.94 | 2019 | |
| Medtronic, INC. | $16.53 | 2023 | Intellis Adaptivestim |
| Cumberland Pharmaceuticals, INC. | $16.28 | 2020 | |
| Scilex Pharmaceuticals INC. | $14.09 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Randall Barrett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.